Skip to main content
Signal8

Dreismann Heinrich

SEC insider (Form 3/4/5 filer). CIK 0001379372. Director at MYRIAD GENETICS INC (MYGN) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in SALT LAKE CITY, UT.

Companies Dreismann Heinrich has filed insider reports for

  • MYRIAD GENETICS INC (MYGN): Director
  • MAINZ BIOMED N.V. (MYNZ): Director
Dreismann Heinrich profile photo

Dreismann Heinrich

CIK: 0001379372

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

MYRIAD GENETICS INC logo
MYGN

MYRIAD GENETICS INC

Director
MAINZ BIOMED N.V. logo
MYNZ

MAINZ BIOMED N.V.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • MYRIAD GENETICS INC logo
    MYGN

    MYRIAD GENETICS INC

    Jun 4, 2026
    Award
    Direct
    59.7K shares-
  • MAINZ BIOMED N.V. logo
    MYNZ

    MAINZ BIOMED N.V.

    Feb 13, 2026
    Award
    Direct
    45K shares-
  • MYRIAD GENETICS INC logo
    MYGN

    MYRIAD GENETICS INC

    Jun 5, 2025
    Award
    Direct
    49.8K shares-
  • MYRIAD GENETICS INC logo
    MYGN

    MYRIAD GENETICS INC

    Sep 9, 2024
    Sale
    Direct
    10K shares at avg. $27.05$271K

1-4 of 4